Salarius Pharmaceuticals Inc’s recently made public that its Director HANISH ARNOLD C unloaded Company’s shares for reported $10.0 on Dec 30 ’25. In the deal valued at $0.64 per share,15 shares were sold. As a result of this transaction, HANISH ARNOLD C now holds 5,000 shares worth roughly $3250.0.
Then, HANISH ARNOLD C sold 12 shares, generating $8 in total proceeds. Upon selling the shares at $0.64, the Director now owns 0 shares.
Before that, HANISH ARNOLD C bought 5,000 shares. Salarius Pharmaceuticals Inc shares valued at $3,740 were divested by the Director at a price of $0.75 per share. As a result of the transaction, HANISH ARNOLD C now holds 5,015 shares, worth roughly $3259.75.
Ladenburg Thalmann initiated its Salarius Pharmaceuticals Inc [SLRX] rating to a Buy in a research note published on April 27, 2020; the price target was $3.80.
Price Performance Review of SLRX
On Friday, Salarius Pharmaceuticals Inc [NASDAQ:SLRX] saw its stock jump 0.49% to $0.65. Over the last five days, the stock has gained 2.52%. Salarius Pharmaceuticals Inc shares have fallen nearly -97.14% since the year began. Nevertheless, the stocks have risen 0.49% over the past one year. While a 52-week high of $108.00 was reached on 01/02/26, a 52-week low of $0.62 was recorded on 01/02/26.
Levels Of Support And Resistance For SLRX Stock
The 24-hour chart illustrates a support level at 0.6387, which if violated will result in even more drops to 0.6255. On the upside, there is a resistance level at 0.6676. A further resistance level may holdings at 0.6833.
How much short interest is there in Salarius Pharmaceuticals Inc?
A steep rise in short interest was recorded in Salarius Pharmaceuticals Inc stocks on 2025-12-15, dropping by -0.28 million shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.47 million shares. There was a decline of -153.4%, which implies that there is a negative sentiment for the stock.
